Browse the complete record of transactions filed by NORTHCOTT JOHN, Directeur Commercial. Officer active across 2 companies, notably Nektar Therapeutics. Cumulatively, 11 disclosures have been logged. Total volume traded: €580k. The latest transaction was disclosed on 16 May 2022 (Cession). Regulator: SEC (Form 4). The full history is openly available.
John Northcott is Senior Vice President and Chief Commercial Officer at Nektar Therapeutics. He oversees the company's commercial and marketing efforts, ensuring that products effectively reach the market. His experience in the biopharmaceutical industry is crucial for the organization's success.